{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T05:07:03Z","timestamp":1780463223029,"version":"3.54.1"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To characterize global steroid hormone dysregulation and the androgen profile in adolescent girls with polycystic ovary syndrome (PCOS), and to explore adrenal versus ovarian androgen origins using a dexamethasone suppression test combined with liquid chromatography-tandem mass spectrometry (LC-MS\/MS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We consecutively enrolled 37 adolescent PCOS patients and 22 age-matched healthy controls. PCOS diagnosis followed the 2023 international evidence-based recommendations. All participants underwent clinical evaluation and LC-MS\/MS steroid profiling; 24 PCOS patients also received a dexamethasone suppression test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Compared with healthy controls, the PCOS group had elevated levels of multiple androgens, including dehydroepiandrosterone (DHEA), dehydroepiandrosterone sulfate (DHEA-S), androstenedione (AD), total testosterone (TT), androsterone (ADT), dihydrotestosterone (DHT), 11\u03b2-hydroxyandrostenedione (11-OHAD), 11\u03b2-hydroxytestosterone (11-OHT), and epitestosterone (EpiT), as well as estrone, pregnenolone, and 17-hydroxyprogesterone, along with decreased sex hormone-binding globulin (SHBG). Spearman correlation showed that DHEA-S explained only limited variation in 11-OHAD (r\n                      <jats:sub>s<\/jats:sub>\n                      = 0.629,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0&amp;lt;\u00a00.001). ROC analysis identified the free androgen index (FAI) as the best diagnostic marker (AUC\u00a0=\u00a00.976, sensitivity 91.7%, specificity 87.0% at cutoff 4.27). FAI alone was elevated in 86.5% of PCOS patients; adding total testosterone and androstenedione increased detection to 97.3%. In the dexamethasone suppression test, DHEA, DHEA-S, and 11-oxygenated androgens were markedly suppressed (median inhibition 81.9%\u201392.2%), whereas testosterone suppression was minimal (14.0%,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.522). Notably, baseline DHEA-S was not elevated in most patients with significant androgen suppression, indicating discordance between suppression-test-defined adrenal dominance and traditional DHEA-S criteria.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Adolescent girls with PCOS exhibit widespread androgen abnormalities. FAI demonstrates the highest diagnostic value, and the addition of total testosterone and androstenedione modestly improves detection. The dexamethasone suppression test suggests that most 11-oxygenated androgens are of adrenal origin, whereas testosterone suppression is minimal. Elevated DHEA-S levels are not consistently aligned with adrenal-origin androgen dominance defined by the suppression test. These findings warrant further validation in larger populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1817505","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T04:52:37Z","timestamp":1780462357000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Androgen profiling in adolescent girls with polycystic ovary syndrome"],"prefix":"10.3389","volume":"17","author":[{"given":"Xuan","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Pediatrics, The Second Hospital of Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The Second Hospital of Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemeng","family":"Chong","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The Second Hospital of Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Xing","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The Second Hospital of Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuehan","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The Second Hospital of Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueqiu","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The Second Hospital of Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xujing","family":"Kong","sequence":"additional","affiliation":[{"name":"Kingmed Diagnostics (Beijing) Co., Ltd","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susu","family":"Cai","sequence":"additional","affiliation":[{"name":"Kingmed Diagnostics (Beijing) Co., Ltd","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baorong","family":"Chen","sequence":"additional","affiliation":[{"name":"Kingmed Diagnostics (Beijing) Co., Ltd","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The Second Hospital of Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifeng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The Second Hospital of Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab827","article-title":"Pcos and mendelian randomization: Too soon","volume":"107","author":"Azziz","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"B2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12916-025-03901-w","article-title":"International evidence-based recommendations for polycystic ovary syndrome in adolescents","volume":"23","author":"Pe\u00f1a","year":"2025","journal-title":"BMC Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2025.09.006","article-title":"Update on diagnosis of polycystic ovary syndrome during adolescence","volume":"124","author":"Pe\u00f1a","year":"2025","journal-title":"Fertil Steril"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-00241","article-title":"Evaluation and treatment of hirsutism in premenopausal women: An endocrine society clinical practice guideline","volume":"103","author":"Martin","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/s0015-0282(02)02985-0","article-title":"Androgen production in women","volume":"77","author":"Burger","year":"2002","journal-title":"Fertil Steril"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911952","article-title":"The roles of androgens in humans: Biology, metabolic regulation and health","volume":"23","author":"Alemany","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1210\/clinem\/dgaf527","article-title":"On the intimate relationship of adiposity to polycystic ovary syndrome","volume":"111","author":"Rosenfield","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-022-02625-7","article-title":"A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS)","volume":"39","author":"Siddiqui","year":"2022","journal-title":"J Assist Reprod Genet"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic ovary syndrome: Definition, aetiology, diagnosis and treatment","volume":"14","author":"Escobar-Morreale","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/edm2.70022","article-title":"Exploring the predictive role of 11\u2010oxyandrogens in diagnosing polycystic ovary syndrome","volume":"8","author":"Mody","year":"2025","journal-title":"Endocrino Diabetes Metabol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-020-0336-x","article-title":"11-oxygenated androgens in health and disease","volume":"16","author":"Turcu","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.6065\/apem.2244124.062","article-title":"Classic and backdoor pathways of androgen biosynthesis in human sexual development","volume":"27","author":"Lee","year":"2022","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2016.07.029","article-title":"Genes and proteins of the alternative steroid backdoor pathway for dihydrotestosterone synthesis are expressed in the human ovary and seem enhanced in the polycystic ovary syndrome","volume":"441","author":"Marti","year":"2017","journal-title":"Mol Cell Endocrinol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12905-023-02173-x","article-title":"Prevalence of polycystic ovary syndrome under NIH criteria among the tenth-grade Chinese schoolgirls in Guangzhou area: A cross-sectional epidemiological survey","volume":"23","author":"Hong","year":"2023","journal-title":"BMC Womens Health"},{"key":"B15","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13048-021-00781-5","article-title":"Comparison of the efficacy of different androgens measured by LC-MS\/MS in representing hyperandrogenemia and an evaluation of adrenal-origin androgens with a dexamethasone suppression test in patients with PCOS","volume":"14","author":"Chen","year":"2021","journal-title":"J Ovarian Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2025.115239","article-title":"Preparation of magnetic molecularly imprinted polymers using genistein as a virtual template and their application in the separation and detection of 29 steroid hormones by UPLC-MS\/MS","volume":"218","author":"Bu","year":"2025","journal-title":"Microchem J"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232314691","article-title":"Design and validation of a sensitive multisteroid LC-MS\/MS assay for the routine clinical use: One-step sample preparation with phospholipid removal and comparison to immunoassays","volume":"23","author":"Braun","year":"2022","journal-title":"IJMS"},{"key":"B18","volume-title":"Statistik und forschungsmethoden: lehrbuch","author":"Eid","year":"2017"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab920","article-title":"Clinical value of serum levels of 11-oxygenated metabolites of testosterone in women with polycystic ovary syndrome","volume":"107","author":"Tosi","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(21)00235-7","article-title":"Consensus on diagnosis and management of Cushing\u2019s disease: A guideline update","volume":"9","author":"Fleseriu","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14176246","article-title":"Stimulated hyperinsulinemia is independently associated with higher serum DHEAS in PCOS: A retrospective study","volume":"14","author":"Baculescu","year":"2025","journal-title":"J Clin Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/cphy.c140006","article-title":"Adrenal androgens and androgen precursors-definition, synthesis, regulation and physiologic actions","volume":"4","author":"Turcu","year":"2014","journal-title":"Compr Physiol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/s0031-3955(16)37014-6","article-title":"Hyperandrogenism in peripubertal girls","volume":"37","author":"Rosenfield","year":"1990","journal-title":"Pediatr Clin North Am"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199509283331307","article-title":"Polycystic ovary syndrome","volume":"333","author":"Franks","year":"1995","journal-title":"N Engl J Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnae007","article-title":"The search for the causes of common hyperandrogenism, 1965 to circa 2015","volume":"45","author":"Rosenfield","year":"2024","journal-title":"Endocr Rev"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031122","article-title":"Androgen excess in women: Experience with over 1000 consecutive patients","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1530\/REP-25-0091","article-title":"Polycystic ovary syndrome: Origins and implications: The significance of functional adrenal hyperandrogenism in polycystic ovary syndrome across the lifespan","volume":"169","author":"Torchen","year":"2025","journal-title":"Reproduction"},{"key":"B28","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1515\/almed-2023-0020","article-title":"Recommendations for the measurement of sexual steroids in clinical practice. A position statement of SEQCML\/SEEN\/SEEP","volume":"4","author":"Casals","year":"2023","journal-title":"Adv Lab Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/humupd\/dmae028","article-title":"Evaluating the diagnostic accuracy of androgen measurement in polycystic ovary syndrome: A systematic review and diagnostic meta-analysis to inform evidence-based guidelines","volume":"31","author":"Bizuneh","year":"2025","journal-title":"Hum Reprod Update"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-020922","article-title":"The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women","volume":"88","author":"Kaltsas","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0000000000000334","article-title":"Clinical significance of 11-oxygenated androgens","volume":"24","author":"Turcu","year":"2017","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2006.12.058","article-title":"Sex, drugs and sports: Prostaglandins, epitestosterone and sexual development","volume":"69","author":"Sanders","year":"2007","journal-title":"Med Hypotheses"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/srep32198","article-title":"Dihydrotestosterone synthesis pathways from inactive androgen 5\u03b1-androstane-3\u03b2,17\u03b2-diol in prostate cancer cells: Inhibition of intratumoural 3\u03b2-hydroxysteroid dehydrogenase activities by abiraterone","volume":"6","author":"Ando","year":"2016","journal-title":"Sci Rep"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/der291","article-title":"Determination of the source of androgen excess in functionally atypical polycystic ovary syndrome by a short dexamethasone androgen-suppression test and a low-dose ACTH test","volume":"26","author":"Rosenfield","year":"2011","journal-title":"Hum Reprod"},{"key":"B35","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/ejendo\/lvae008","article-title":"Reference intervals for serum 11-oxygenated androgens in children","volume":"190","author":"Adriaansen","year":"2024","journal-title":"Eur J Endocrinol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2025-1440","article-title":"Age- and sex-specific reference intervals for 11-oxygenated androgens from infancy throughout childhood and adulthood","author":"Zeidler","year":"2026","journal-title":"Clin Chem Lab Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"108748","DOI":"10.1016\/j.steroids.2020.108748","article-title":"Circulating steroids and mood disorders in patients with polycystic ovary syndrome","volume":"165","author":"Yoshida","year":"2021","journal-title":"Steroids"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-3285","article-title":"11-oxygenated C19 steroids are the predominant androgens in polycystic ovary syndrome","volume":"102","author":"O\u2019Reilly","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-020-0870-1","article-title":"Steroid hormone analysis of adolescents and young women with polycystic ovarian syndrome and adrenocortical dysfunction using UPC2 -MS\/MS","volume":"89","author":"Swart","year":"2021","journal-title":"Pediatr Res"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1817505\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T04:52:41Z","timestamp":1780462361000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1817505\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":39,"alternative-id":["10.3389\/fendo.2026.1817505"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1817505","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"article-number":"1817505"}}